人口
功能性食品
风险分析(工程)
健康福利
业务
医学
生物技术
人类健康
对偶(语法数字)
医疗保健
食品
全球人口
营养学
价值(数学)
慢性病
工程伦理学
营销
特殊人群
管理科学
健康管理体系
领域(数学)
替代医学
双重角色
新奇的食物
基础研究
梅德林
人口健康
传统医学
世界人口
作者
X. X. Xi,Songhua Hu,Xunuo Zhang,Peng An,Yongting Luo,Junjie Luo,Yinhua Zhu
标识
DOI:10.1016/j.advnut.2025.100546
摘要
With rising global attention to health and the accelerating trend of population aging, the demand for Foods for Special Medical Purposes (FSMPs) has increased substantially. These products are formulated not only to meet the basic nutritional needs of individuals with specific diseases or physiological conditions but also to provide regulatory physiological effects. In this context, the "Food-As-Medicine" (FAM) concept has gained growing interest. FAM seeks to prevent and treat diseases through the incorporation of functional foods into health management strategies and aligns closely with the traditional Chinese medicine (TCM) theory of "Food-Medicine Homologous" (FMH). Guided by FMH principles, natural bioactive compounds such as polysaccharides, flavonoids, and saponins have drawn significant attention for their anti-inflammatory, antioxidant, and immunomodulatory properties. However, their broader application faces several challenges, including low extraction efficiency, complex purification procedures, and difficulties in ensuring stability, all of which hinder industrial-scale development. This review systematically explores the potential, challenges, and opportunities of FMH-based products in FSMPs, with a particular emphasis on infant nutrition, maternal health, and the management of chronic diseases in the elderly. Our findings highlight the dual value of FMH ingredients in both nutritional support and functional modulation. Furthermore, by integrating FMH theory with modern nutritional science, this review offers a scientific basis for the innovative development of FSMPs. Given the growing global market demand and the increasing dissemination of TCM culture, this field is poised to enter a new phase of development.
科研通智能强力驱动
Strongly Powered by AbleSci AI